WallStreetZenWallStreetZen

NASDAQ: NTLA
Intellia Therapeutics Inc Stock Ownership - Who owns Intellia Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Intellia Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
William J. ChaseDirector2025-08-20100,000$10.03
$1.00MBuy
Edward J. Dulac IiiEVP Chief Financial Officer2025-07-237,462$14.02
$104.62kSell
Michael P. DubeVP Chief Accounting Officer2025-07-022,503$9.95
$24.90kSell
Jesse GoodmanDirector2025-07-011,547$9.23
$14.28kSell
Eliana ClarkEVP Chief Technical Officer2025-07-011,022$9.82
$10.04kSell
Jesse GoodmanDirector2025-06-301,547$9.56
$14.79kSell
Muna BhanjiDirector2025-04-29265$8.50
$2.25kSell
James BastaEVP General Counsel2025-03-042,572$8.99
$23.12kSell
Eliana ClarkEVP Chief Technical Officer2025-03-04679$8.99
$6.10kSell
Muna BhanjiDirector2025-01-29265$9.97
$2.64kSell

1 of 2

NTLA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NTLA insiders and whales buy or sell their stock.

NTLA Shareholders

What type of owners hold Intellia Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ark Investment Management LLC12.57%13,017,876$159.73MInstitution
Vanguard Group Inc10.48%10,852,169$133.16MInstitution
Blackrock Inc9.68%10,027,175$123.03MInstitution
Rachel E. Haurwitz5.40%5,593,846$68.64MInsider
Caribou Therapeutics Holdco LLC5.40%5,593,846$68.64MInsider
Novartis Institutes For Biomedical Research Inc4.20%4,352,295$53.40MInsider
Morgan Stanley3.97%4,116,861$50.51MInstitution
State Street Corp3.90%4,039,285$49.56MInstitution
Caribou Biosciences Inc3.86%3,994,355$49.01MInsider
Atlas Venture Associates IX LP3.60%3,729,788$45.76MInsider

1 of 3

NTLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NTLA71.81%28.19%Net BuyingNet Buying
YDES0.00%3.67%
RCUS63.74%36.26%Net BuyingNet Selling
SNDX91.99%8.01%Net BuyingNet Selling
PHVS82.28%0.00%
View Top Biotech Stocks

Intellia Therapeutics Stock Ownership FAQ

Who owns Intellia Therapeutics?

Intellia Therapeutics (NASDAQ: NTLA) is owned by 96.08% institutional shareholders, 37.71% Intellia Therapeutics insiders, and 0.00% retail investors. Rachel E. Haurwitz is the largest individual Intellia Therapeutics shareholder, owning 5.59M shares representing 5.40% of the company. Rachel E. Haurwitz's Intellia Therapeutics shares are currently valued at $69.42M.

If you're new to stock investing, here's how to buy Intellia Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.